These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29195048)

  • 1. Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic.
    Gothwal A; Khan I; Kumar P; Raza K; Kaul A; Mishra AK; Gupta U
    Mol Pharm; 2018 Jun; 15(6):2084-2097. PubMed ID: 29195048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled PLGA Nanoparticles for Effective Targeting of Bendamustine in Tumor Bearing Mice.
    Khan I; Gothwal A; Kaul A; Mathur R; Mishra AK; Gupta U
    Pharm Res; 2018 Aug; 35(11):200. PubMed ID: 30171428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
    Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
    Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
    Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.
    Khan I; Gothwal A; Sharma AK; Qayum A; Singh SK; Gupta U
    Int J Biol Macromol; 2016 Nov; 92():1242-1251. PubMed ID: 27527691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
    Wang B; Navath RS; Romero R; Kannan S; Kannan R
    Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a PAMAM Dendrimer for Sustained Release of Temozolomide against Experimental Murine Lymphoma: Assessment of Therapeutic Efficacy.
    Sk UH; Hira SK; Rej A; RoyMahapatra D; Manna PP
    ACS Appl Bio Mater; 2021 Mar; 4(3):2628-2638. PubMed ID: 35014379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies.
    Cracchiolo MJ; Davis L; Matiatos AP; Davini DW; Husnain M; Simpson RJ; Voudouris V; Katsanis E
    Cancer Chemother Pharmacol; 2024 Sep; 94(3):361-372. PubMed ID: 38878208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
    Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
    Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents.
    Scutaru AM; Wenzel M; Scheffler H; Wolber G; Gust R
    Bioconjug Chem; 2010 Oct; 21(10):1728-43. PubMed ID: 20849062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
    Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
    Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
    Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
    J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
    Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
    Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated Dendrimer Mediated Delivery of Bortezomib: Drug Conjugation versus Encapsulation.
    Sahoo RK; Gothwal A; Rani S; Nakhate KT; Ajazuddin ; Gupta U
    Int J Pharm; 2020 Jun; 584():119389. PubMed ID: 32380027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
    Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U
    ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.
    Ma P; Yu H; Zhang X; Mu H; Chu Y; Ni L; Xing P; Wang Y; Sun K
    Pharm Res; 2017 Jan; 34(1):121-135. PubMed ID: 27848167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
    Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
    Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
    Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
    Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
    Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
    Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.